87 related articles for article (PubMed ID: 21165671)
1. The myosin ATPase inhibitor, 2,3-butanedione 2-monoxime, prevents protein secretion by the basidiomycete Coprinopsis cinerea.
Hashimoto K; Yokota E; Shimmen T; Yoshida M
Biotechnol Lett; 2011 Apr; 33(4):769-75. PubMed ID: 21165671
[TBL] [Abstract][Full Text] [Related]
2. 2,3-Butanedione monoxime (BDM) as a myosin inhibitor.
Ostap EM
J Muscle Res Cell Motil; 2002; 23(4):305-8. PubMed ID: 12630704
[TBL] [Abstract][Full Text] [Related]
3. Effects of myosin ATPase inhibitor 2,3-butanedione 2-monoxime on distributions of myosins, F-actin, microtubules, and cortical endoplasmic reticulum in maize root apices.
Samaj J; Peters M; Volkmann D; Baluska F
Plant Cell Physiol; 2000 May; 41(5):571-82. PubMed ID: 10929940
[TBL] [Abstract][Full Text] [Related]
4. Does 2,3-butanedione monoxime inhibit nonmuscle myosin?
Forer A; Fabian L
Protoplasma; 2005 Apr; 225(1-2):1-4. PubMed ID: 15868207
[TBL] [Abstract][Full Text] [Related]
5. Effects of the myosin inhibitor 2,3-butanedione monoxime on the physiology of fission yeast.
Steinberg G; McIntosh JR
Eur J Cell Biol; 1998 Dec; 77(4):284-93. PubMed ID: 9930653
[TBL] [Abstract][Full Text] [Related]
6. The myosin ATPase inhibitor 2,3-butanedione monoxime dictates transcriptional activation of ion channels and Ca(2+)-handling proteins.
Borlak J; Zwadlo C
Mol Pharmacol; 2004 Sep; 66(3):708-17. PubMed ID: 15322264
[TBL] [Abstract][Full Text] [Related]
7. The myosin ATPase inhibitor 2,3-butanedione-2-monoxime (BDM) inhibits tip growth and cytokinesis in the fission yeast, Schizosaccharomyces pombe.
May KM; Wheatley SP; Amin V; Hyams JS
Cell Motil Cytoskeleton; 1998; 41(2):117-25. PubMed ID: 9786087
[TBL] [Abstract][Full Text] [Related]
8. The myosin ATPase inhibitor 2,3-butanedione-2-monoxime disorganizes microtubules as well as F-actin in Saccharomyces cerevisiae.
Chon K; Hwang HS; Lee JH; Song K
Cell Biol Toxicol; 2001; 17(6):383-93. PubMed ID: 11787860
[TBL] [Abstract][Full Text] [Related]
9. Myosin motors and not actin comets are mediators of the actin-based Golgi-to-endoplasmic reticulum protein transport.
Durán JM; Valderrama F; Castel S; Magdalena J; Tomás M; Hosoya H; Renau-Piqueras J; Malhotra V; Egea G
Mol Biol Cell; 2003 Feb; 14(2):445-59. PubMed ID: 12589046
[TBL] [Abstract][Full Text] [Related]
10. The motility of Chara corallina myosin was inhibited reversibly by 2,3-butanedione monoxime (BDM).
Funaki K; Nagata A; Akimoto Y; Shimada K; Ito K; Yamamoto K
Plant Cell Physiol; 2004 Sep; 45(9):1342-5. PubMed ID: 15509860
[TBL] [Abstract][Full Text] [Related]
11. 2,3-butanedione monoxime (BDM), a potent inhibitor of actin-myosin interaction, induces ion and fluid transport in MDCK monolayers.
Castillo AM; Reyes JL; Sánchez E; Mondragón R; Meza I
J Muscle Res Cell Motil; 2002; 23(3):223-34. PubMed ID: 12500902
[TBL] [Abstract][Full Text] [Related]
12. BDM (2,3-butanedione monoxime), an inhibitor of myosin-actin interaction, suppresses myofibrillogenesis in skeletal muscle cells in culture.
Soeno Y; Shimada Y; Obinata T
Cell Tissue Res; 1999 Feb; 295(2):307-16. PubMed ID: 9931377
[TBL] [Abstract][Full Text] [Related]
13. Modulation of IP(3)-sensitive Ca(2+) release by 2,3-butanedione monoxime.
Turvey MR; Laude AJ; Ives EO; Seager WH; Taylor CW; Thorn P
Pflugers Arch; 2003 Feb; 445(5):614-21. PubMed ID: 12634934
[TBL] [Abstract][Full Text] [Related]
14. Actomyosin promotes cell plate alignment and late lateral expansion in Tradescantia stamen hair cells.
Molchan TM; Valster AH; Hepler PK
Planta; 2002 Mar; 214(5):683-93. PubMed ID: 11882936
[TBL] [Abstract][Full Text] [Related]
15. Effects of anti-myosin drugs on anaphase chromosome movement and cytokinesis in crane-fly primary spermatocytes.
Silverman-Gavrila RV; Forer A
Cell Motil Cytoskeleton; 2001 Dec; 50(4):180-97. PubMed ID: 11807939
[TBL] [Abstract][Full Text] [Related]
16. Dynamic rearrangements of transvacuolar strands in BY-2 cells imply a role of myosin in remodeling the plant actin cytoskeleton.
Hoffmann A; Nebenführ A
Protoplasma; 2004 Dec; 224(3-4):201-10. PubMed ID: 15614481
[TBL] [Abstract][Full Text] [Related]
17. Effect of 2,3-butanedione monoxime on myosin and myofibrillar ATPases. An example of an uncompetitive inhibitor.
Herrmann C; Wray J; Travers F; Barman T
Biochemistry; 1992 Dec; 31(48):12227-32. PubMed ID: 1457420
[TBL] [Abstract][Full Text] [Related]
18. Effects of the myosin inhibitor 2,3-butanedione monoxime (BDM) on cell shape, locomotion and fluid pinocytosis in human polymorphonuclear leucocytes.
Urwyler N; Eggli P; Keller HU
Cell Biol Int; 2000; 24(12):863-70. PubMed ID: 11114235
[TBL] [Abstract][Full Text] [Related]
19. Involvement of myosin in intracellular motility and cytomorphogenesis in Micrasterias.
Oertel A; Holzinger A; Lütz-Meindl U
Cell Biol Int; 2003; 27(12):977-86. PubMed ID: 14642529
[TBL] [Abstract][Full Text] [Related]
20. Reprogramming of gene expression in cultured cardiomyocytes and in explanted hearts by the myosin ATPase inhibitor butanedione monoxime.
Thum T; Borlak J
Transplantation; 2001 Feb; 71(4):543-52. PubMed ID: 11258434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
